167 related articles for article (PubMed ID: 10082132)
1. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
Ouyang X; Gulliford T; Huang G; Epstein RJ
J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
[TBL] [Abstract][Full Text] [Related]
2. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
Gulliford TJ; Huang GC; Ouyang X; Epstein RJ
Oncogene; 1997 Oct; 15(18):2219-23. PubMed ID: 9393980
[TBL] [Abstract][Full Text] [Related]
3. Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1.
Skarpen E; Johannessen LE; Bjerk K; Fasteng H; Guren TK; Lindeman B; Thoresen GH; Christoffersen T; Stang E; Huitfeldt HS; Madshus IH
Exp Cell Res; 1998 Aug; 243(1):161-72. PubMed ID: 9716460
[TBL] [Abstract][Full Text] [Related]
4. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
Jiang D; Liang J; Humphrey LE; Yang H; Brattain MG
J Cell Physiol; 1998 May; 175(2):174-83. PubMed ID: 9525476
[TBL] [Abstract][Full Text] [Related]
5. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes.
Sharif A; Prévot V; Renault-Mihara F; Allet C; Studler JM; Canton B; Chneiweiss H; Junier MP
Oncogene; 2006 Jul; 25(29):4076-85. PubMed ID: 16532035
[TBL] [Abstract][Full Text] [Related]
7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism.
Huang G; Chantry A; Epstein RJ
J Cell Biochem; 1999 Jul; 74(1):23-30. PubMed ID: 10381258
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
10. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
[TBL] [Abstract][Full Text] [Related]
11. Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells.
Yang H; Jiang D; Li W; Liang J; Gentry LE; Brattain MG
Oncogene; 2000 Apr; 19(15):1901-14. PubMed ID: 10773880
[TBL] [Abstract][Full Text] [Related]
12. The enlargement of the hormone immune deprivation concept to the blocking of TGFalpha-autocrine loop: EGFR signaling inhibition.
Mulet A; Garrido G; Alvarez A; Menéndez T; Böhmer FD; Pérez R; Fernández LE
Cancer Immunol Immunother; 2006 Jun; 55(6):628-38. PubMed ID: 16328386
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel EGF-sensitive cell cycle checkpoint.
Walker F; Zhang HH; Burgess AW
Exp Cell Res; 2007 Feb; 313(3):511-26. PubMed ID: 17157295
[TBL] [Abstract][Full Text] [Related]
14. Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF alpha prior to neoplasia.
Charalambous CT; Hannigan A; Tsimbouri P; McPhee GM; Wilson JB
Carcinogenesis; 2007 Aug; 28(8):1839-48. PubMed ID: 17361012
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
17. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor.
Pangburn HA; Ahnen DJ; Rice PL
Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299
[TBL] [Abstract][Full Text] [Related]
18. HB-EGF promotes epithelial cell migration in eyelid development.
Mine N; Iwamoto R; Mekada E
Development; 2005 Oct; 132(19):4317-26. PubMed ID: 16141218
[TBL] [Abstract][Full Text] [Related]
19. Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2.
Bindels EM; van der Kwast TH; Izadifar V; Chopin DK; de Boer WI
Urol Res; 2002 Sep; 30(4):240-7. PubMed ID: 12202942
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]